Challenges in the pharmaceutical development of lipid-based short interfering ribonucleic acid therapeutics

Author： Gindy Marian E   Leone Anthony M   Cunningham James J  

Publisher： Informa Healthcare

ISSN： 1742-5247

Source： Expert Opinion on Drug Delivery, Vol.9, Iss.2, 2012-02, pp. : 171-182

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Short interfering RNA and the central nervous system: development of nonviral delivery systems

By Nishina Kazutaka   Mizusawa Hidehiro   Yokota Takanori  

Expert Opinion on Drug Delivery, Vol. 10, Iss. 3, 2013-03 ,pp. : 289-292

Informa Healthcare

Access to resources Recommend Favorite

Lipid-based carriers: manufacturing and applications for pulmonary route

By Jaafar-Maalej Chiraz   Elaissari Abdelhamid   Fessi Hatem  

Expert Opinion on Drug Delivery, Vol. 9, Iss. 9, 2012-09 ,pp. : 1111-1127

Informa Healthcare

Access to resources Recommend Favorite

Cutaneous short-interfering RNA therapy

By Geusens B   Sanders N   Prow T   Van Gele M   Lambert J  

Expert Opinion on Drug Delivery, Vol. 6, Iss. 12, 2009-12 ,pp. : 1333-1349

Informa Healthcare

Access to resources Recommend Favorite

Oral delivery of peptides and proteins using lipid-based drug delivery systems

By Li Ping   Nielsen Hanne Mørck   Müllertz Anette  

Expert Opinion on Drug Delivery, Vol. 9, Iss. 10, 2012-10 ,pp. : 1289-1304

Informa Healthcare

Access to resources Recommend Favorite

Lipid-based oral multiparticulate formulations –– advantages, technological advances and industrial applications

By Shukla Dali   Chakraborty Subhashis   Singh Sanjay   Mishra Brahmeshwar  

Expert Opinion on Drug Delivery, Vol. 8, Iss. 2, 2011-02 ,pp. : 207-224

Informa Healthcare

Access to resources Recommend Favorite